The new World Health Organization guideline recognizes obesity as a chronic disease that can be treated with drug therapy as ...
Ozempic-style medications have been endorsed as long-term treatments for obesity under new guidelines released by the World ...
Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.
Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic ...
News-Medical.Net on MSN
Semaglutide helps older adults lose weight without immediate bone loss
By Tarun Sai Lomte A small but carefully monitored 20-week study reveals that semaglutide delivers weight loss in older ...
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...
While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...
Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for ...
The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...
MedPage Today on MSN
GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids
News and commentary from the endocrinology world ...
In Naples, on Wednesday, December 3rd, the IRCCS Fondazione Pascale hosted the congress 'Cancer and Obesity: A Strong Often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback